CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,115,043 | -7.2% | 1,932,153 | +32.7% | 0.11% | -18.2% |
| Q4 2022 | $8,748,090 | +21.0% | 1,455,589 | -41.4% | 0.14% | +67.1% |
| Q3 2022 | $7,231,224 | -5.7% | 2,482,622 | +93.3% | 0.08% | -46.1% |
| Q2 2022 | $7,667,000 | +65.0% | 1,284,325 | +29.0% | 0.15% | +171.4% |
| Q1 2022 | $4,648,000 | +63.7% | 995,280 | -13.1% | 0.06% | +180.0% |
| Q4 2021 | $2,840,000 | -15.2% | 1,145,280 | +0.8% | 0.02% | -31.0% |
| Q3 2021 | $3,351,000 | +36.9% | 1,136,049 | +16.1% | 0.03% | +31.8% |
| Q2 2021 | $2,447,000 | -24.4% | 978,679 | -12.0% | 0.02% | -38.9% |
| Q1 2021 | $3,235,000 | +1.5% | 1,111,680 | +12.3% | 0.04% | +28.6% |
| Q4 2020 | $3,187,000 | +92.3% | 989,602 | +28.4% | 0.03% | -15.2% |
| Q3 2020 | $1,657,000 | +3665.9% | 770,731 | +6761.3% | 0.03% | +1000.0% |
| Q1 2018 | $44,000 | – | 11,233 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 6,535,674 | $27,449,831 | 9.21% |
| Bleichroeder LP | 3,893,730 | $16,353,666 | 3.49% |
| AIGH Capital Management LLC | 2,100,000 | $8,820,000 | 3.25% |
| Ally Bridge Group (NY) LLC | 550,000 | $2,310,000 | 3.03% |
| Ghost Tree Capital, LLC | 2,000,000 | $8,400,000 | 2.48% |
| Bain Capital Life Sciences Investors, LLC | 4,702,996 | $19,753 | 2.47% |
| Altium Capital Management LP | 850,000 | $3,570,000 | 1.98% |
| Parkman Healthcare Partners LLC | 1,753,630 | $7,365,246 | 1.60% |
| BVF INC/IL | 8,813,021 | $37,014,688 | 1.35% |
| Sio Capital Management, LLC | 526,239 | $2,210,204 | 1.09% |